Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Pathology International|December 18, 2025
Significance and Utility of Immunohistochemical MTAP Expression to Predict CDKN2A Genomic Status in Diffuse Large B-Cell LymphomaKozue Ito, Hiroki Imada, Marino Nagata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2015
[Cardiac and breast diffuse large B-cell lymphoma with pericardial effusion and AV-block]Tatsuki Tomikawa, Takayuki Tabayashi, Michihide Tokuhira, et al.
Leukemia|June 15, 2019
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemiaNeus Giménez, Ralph Schulz, Morihiro Higashi, et al.
Scientific Reports|November 6, 2020
Endocytoscopic observation with methylene blue staining for duodenal neoplasms associated with familial adenomatous polyposisYouichi Kumagai, Eisuke Yamamoto, Morihiro Higashi, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 13, 2018
Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinomaYouichi Kumagai, Tetsuhiko Tachikawa, Morihiro Higashi, et al.
Cancer Science|June 3, 2025
Genetic Profiling Reveals the Distinctions Among MTX-Associated DLBCL, EBV-Positive Mucocutaneous Ulcer, and EBV + DLBCLTakumi Takahashi, Keisuke Sawada, Takahisa Yamashita, et al.
Leukemia & Lymphoma|April 6, 2019
Clinicopathological features of clinical methotrexate-related lymphoproliferative disordersMichihide Tokuhira, Shuntaro Saito, Katsuya Suzuki, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|February 16, 2006
Urinary dysfunction and autonomic control in amyloid neuropathyTakashi Ito, Ryuji Sakakibara, Tatsuya Yamamoto, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|April 1, 2026
CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexateKeisuke Sawada, Takumi Takahashi, Yuki Fukumura, et al.
Life Science Alliance|August 10, 2023
SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemiaIrene López-Oreja, André Gohr, Heribert Playa-Albinyana, et al.
Pageof 8